Göm menyn

Publications for Christina Hedman

Co-author map based on Web of Sciences articles 2007-

Publications mentioned in social media 4 times*

Journal Articles

Kerstin Gutefeldt, Christina A Hedman, Ingrid S M Thyberg, Margareta Bachrach-Lindström, Hans Arnqvist and Anna Spångeus
  Upper extremity impairments in type 1 diabetes with long duration: common problems with great impact on daily life
  Disability and Rehabilitation, 2017, , 1-8.

Peter R. van Dijk, Susan J. J. Logtenberg, Ioana Simona Chisalita, Christina Hedman, Klaas H. Groenier, Reinold O. B. Gans, Nanne Kleefstra, Hans Arnqvist and Henk J. G. Bilo
  Different Effects of Intraperitoneal and Subcutaneous Insulin Administration on the GH-IGF-1 Axis in Type 1 Diabetes
  Journal of Clinical Endocrinology and Metabolism, 2016, 101(6), 2493-2501.
 Web of Science® Times Cited: 4

Peter R Van dijk, Susan J J Logtenberg, Ioana Simona Chisalita, Christina A. Hedman, Klaas H Groenier, Reinold O B Gans, Nanne Kleefstra, Hans J. Arnqvist and Henk J G Bilo
  After 6years of intraperitoneal insulin administration IGF-I concentrations in T1DM patients are at low-normal level.
  Growth Hormone & IGF Research, 2015, 25(6), 316-319.
 Web of Science® Times Cited: 2

Christina A Hedman, Jan Frystyk, Torbjörn Lindström, Per Oskarsson and Hans J Arnqvist
  Intraperitoneal insulin delivery to patients with type 1 diabetes results in higher serum IGF-I bioactivity than continuous subcutaneous insulin infusion
  Clinical Endocrinology, 2014, 81(1), 58-62.
 Web of Science® Times Cited: 9

Torbjörn Lindström, Jan Frystyk, Christina Hedman, Allan Flyvbjerg and Hans Arnqvist
  Elevated circulating adiponectin in type 1 diabetes is associated with long diabetes duration
  Clinical Endocrinology, 2006, 65(6), 776-782.
 Web of Science® Times Cited: 28

Christina Hedman, Jan Frystyk, Karin Fridell, Anna Jönsson, Allan Flyvbjerg, Torbjörn Lindström and Hans Arnqvist
  The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes
  Growth Hormone & IGF Research, 2005, 15(4), 304-310.
 Web of Science® Times Cited: 4

Christina Hedman, Jan Frystyk, Torbjörn Lindström, Jian-Wen Chen, Allan Flyvbjerg, Hans Ørskov and Hans Arnqvist
  Residual β-cell function more than glycemic control determines abnormalities of the insulin-like growth factor system in type 1 diabetes
  Journal of Clinical Endocrinology and Metabolism, 2004, 89(12), 6305-6309.
 Web of Science® Times Cited: 41

Torbjörn Lindström, Christina Hedman and Hans Arnqvist
  Use of a novel double-antibody technique to describe the pharmacokinetics of rapid-acting insulin analogs
  Diabetes Care, 2002, 25(6), 1049-1054.
 Web of Science® Times Cited: 26

Christina Hedman, Torbjörn Lindström and Hans Arnqvist
  Direct comparison of insulin lispro and aspart shows small differences in plasma insulin profiles after subcutaneous injection in type 1 diabetes
  Diabetes Care, 2001, 24, 1120-1121.
 Web of Science® Times Cited: 53

Christina Hedman, A-C Orre-Pettersson, Torbjörn Lindström and Hans Arnqvist
  Treatment with insulin lispro changes the insulin profile but does not affect the plasma concentrations of IGF-I and IGFBP-1 in type 1 diabetes
  Clinical Endocrinology, 2001, 55(1), 107-112.
 Web of Science® Times Cited: 15

Conference Articles

Christina Hedman, J Frystyk, Torbjörn Lindström, P Oskarsson and Hans Arnqvist
  Intraperitoneal insulin delivery gives higher circulating IGF-I activity than CSII in type 1 diabetes
  in DIABETOLOGIA, vol 52, 2009.

Ph.D. Theses

Christina Hedman
  Insulin and IGF-I in type 1 diabetes

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.


Responsible for this page: Peter Berkesand
Last updated: 2010-08-30